David G Gaiero
CIK 1799784 · Chief Financial Officer · last filed 2024-03-05
David G Gaiero is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider exercised options covering $17.5K of CYT on Mar 5, 2024. Across all open-market trades the lifetime net is −$4.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$37.5K
2
8
-$4.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. (CYT) Delisted | Chief Financial Officer | 102,391 | $3.02 | $309.2K | $0 | 6 | 2024-03-05 |
| WVE | Interim CFO | 6,392 | $5.87 | $37.5K | -$4.6K | 2 | 2020-03-05 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-05 | Cyteir Therapeutics, Inc. (CYT) Delisted | Exer (M) | +10,358 | $17.5K | EDGAR |
| 2023-12-14 | Cyteir Therapeutics, Inc. (CYT) Delisted | Exer (M) | +3,993 | $6.7K | EDGAR |
| 2023-11-22 | Cyteir Therapeutics, Inc. (CYT) Delisted | Exer (M) | +73,940 | $124.4K | EDGAR |
| 2023-02-07 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | +5,000 | $7.5K | EDGAR |
| 2023-02-07 | Cyteir Therapeutics, Inc. (CYT) Delisted | Exer (M) | +4,100 | $6.9K | EDGAR |
| 2022-02-24 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-05 | WVE | Grant (A) | — | $0 | EDGAR |
| 2020-02-05 | WVE | Sell (S) | −651 | -$4.6K | EDGAR |